Skip to content

Study · Case report or series · n = 1 · 2023

1 result

Maturity-onset diabetes of the young type 9 or latent autoimmune diabetes in adults: A case report and review of literature.

Zhou GH, Tao M, Wang Q, Chen XY, Liu J, Zhang LL

World journal of diabetes1 Jul 2023Cited by 1 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: CC BY-NC. Results still quote short attributed sentences.

Results from this study1

1 result from studies that gave the peptide. 1 result from people.

  1. 01HumanCase report or seriesEfficacy outcome

    In a 42-year-old woman with a PAX4 gene mutation and diabetes, blood glucose was under control while she took liraglutide 1.8 mg/d.

    In plain wordsIn one woman with diabetes, blood glucose was under control while she took liraglutide.

    Outcome
    Direction not reportedBlood glucose control on liraglutide
    Study

    n = 1

    Outcome group
    Glycemic control · Metabolic and weight
    Studied dose
    1.8 mg/dAs given in this study (human).

    Source sentences

    Summary
    The patient is currently taking liraglutide (1.8 mg/d), and her blood glucose levels are under control.
    1 context sentence
    Summary · context
    A 42-year-old obese woman suffered diabetes ketoacidosis after consuming substantial amounts of beverages.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    12 Oct 2026, 11:11 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 03:05 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.